Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B.
Jørgensen SF, et al. Among authors: macpherson me.
Sci Rep. 2024 Feb 14;14(1):3704. doi: 10.1038/s41598-024-54117-6.
Sci Rep. 2024.
PMID: 38355714
Free PMC article.
No abstract available.